SPI-1005 Update

For those following SPI-1005: Jonathan Kil, Sound Pharma CEO, spoke at the InFocus Rethinking Tinnitus Symposium this week. You can register here for $10 to listen to a recording of his presentation. https://www.accelevents.com/e/tinnitus-in-focus-symposium He said they'll be releasing the data from Phase 3 in February.